Syndax Pharmaceuticals, Inc. (SNDX)
USD 13.24
(-2.86%)
USD 13.24
(-2.86%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 139.7 Million | 1.51 Million | 1.51 Million | 1.51 Million |
| Cost of Revenue | 12 Thousand | 454 Thousand | 456 Thousand | - | - | - |
| Gross Profit | -12 Thousand | -454 Thousand | 139.25 Million | 1.51 Million | 1.51 Million | 1.51 Million |
| Operating Expenses | 229.95 Million | 151.75 Million | 113.48 Million | 72.94 Million | 59.05 Million | 77.39 Million |
| Selling, General and Administrative Expenses | 66.92 Million | 33.25 Million | 25.24 Million | 22.5 Million | 16.06 Million | 17.28 Million |
| Research and Development Expenses | 163.03 Million | 118.49 Million | 88.24 Million | 50.43 Million | 42.99 Million | 60.1 Million |
| Other Expenses | - | 2.41 Million | -1.29 Million | -1.73 Million | 1.49 Million | 1.91 Million |
| Cost and Expenses | 229.95 Million | 151.75 Million | 113.48 Million | 72.94 Million | 59.05 Million | 77.39 Million |
| Operating Income | -229.95 Million | -151.75 Million | 26.22 Million | -71.42 Million | -57.53 Million | -75.87 Million |
| Interest Expense | 208 Thousand | 3.13 Million | 1.89 Million | 2.35 Million | 1.57 Million | 1.94 Million |
| Income Tax Expense | - | -5.58 Million | -43 Thousand | -89 Thousand | -92 Thousand | 1.91 Million |
| Earnings before Tax | -209.36 Million | -149.33 Million | 24.92 Million | -73.15 Million | -56.04 Million | -73.96 Million |
| Net Income | -209.36 Million | -143.74 Million | 24.92 Million | -73.06 Million | -55.95 Million | -73.96 Million |
| Earnings Per Share Basic | -2.98 | -2.37 | 0.48 | -1.77 | -1.84 | -2.92 |
| Earnings Per Share Diluted | -2.98 | -2.37 | 0.46 | -1.77 | -1.84 | -2.92 |
| Weighted Average Shares Outstanding | 70.37 Million | 60.76 Million | 52.06 Million | 41.3 Million | 30.49 Million | 25.37 Million |
| Weighted Average Shares Outstanding (Diluted) | 70.37 Million | 60.76 Million | 53.62 Million | 41.3 Million | 30.49 Million | 25.37 Million |
| Gross Margin | - | - | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | - | - | 0.19 | -47.08 | -37.93 | -50.02 |
| Profit Margin | - | - | 0.18 | -48.17 | -36.89 | -48.75 |
| EBITDA | -229.94 Million | -151.75 Million | 27.28 Million | -70.28 Million | -55.59 Million | -73.88 Million |
| Earnings Before Tax Margin | - | - | 0.19 | -47.08 | -37.93 | -50.02 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 12.5 Million | 3.5 Million | - | - | 536 Thousand | - |
| Cost of Revenue | - | 44.33 Million | 3000.00 | 12 Thousand | 268 Thousand | 3000.00 |
| Gross Profit | 12.5 Million | -40.83 Million | -3000.00 | -12 Thousand | 268 Thousand | -3000.00 |
| Operating Expenses | 102.07 Million | 77.71 Million | 79.51 Million | 229.94 Million | 77.9 Million | 56.35 Million |
| Selling, General and Administrative Expenses | 31.1 Million | 29.06 Million | 23.02 Million | - | 22.77 Million | 17.26 Million |
| Research and Development Expenses | 70.97 Million | 48.65 Million | 56.48 Million | - | 55.12 Million | 39.08 Million |
| Other Expenses | - | -86 Thousand | -87 Thousand | - | -55 Thousand | -66 Thousand |
| Cost and Expenses | 102.07 Million | 77.71 Million | 79.51 Million | 229.95 Million | 77.9 Million | 56.35 Million |
| Operating Income | -89.57 Million | -74.21 Million | -79.51 Million | -229.95 Million | -77.9 Million | -56.35 Million |
| Interest Expense | -23 Thousand | 45 Thousand | 55 Thousand | 208 Thousand | 63 Thousand | -70 Thousand |
| Income Tax Expense | - | - | -40.27 Thousand | - | 4.99 Million | -3000.00 |
| Earnings before Tax | -84.12 Million | -68.06 Million | -72.4 Million | -209.36 Million | -72.47 Million | -51.14 Million |
| Net Income | -84.12 Million | -68.06 Million | -72.4 Million | -209.36 Million | -72.47 Million | -51.14 Million |
| Earnings Per Share Basic | -0.98 | -0.80 | -0.85 | - | -1.00 | -0.73 |
| Earnings Per Share Diluted | -0.98 | -0.80 | -0.85 | - | -1.00 | -0.73 |
| Weighted Average Shares Outstanding | 85.43 Million | 85.27 Million | 85.21 Million | 70.37 Million | 72.52 Million | 69.85 Million |
| Weighted Average Shares Outstanding (Diluted) | 85.43 Million | 85.27 Million | 85.21 Million | 70.37 Million | 72.52 Million | 69.85 Million |
| Gross Margin | 1.00 | -11.67 | - | - | 0.50 | - |
| EBIT Margin | -7.17 | -21.20 | - | - | -135.09 | - |
| Profit Margin | -6.73 | -19.45 | - | - | -135.21 | - |
| EBITDA | -89.57 Million | -74.21 Million | -79.51 Million | - | -72.4 Million | -56.35 Million |
| Earnings Before Tax Margin | -7.17 | -21.20 | - | - | -145.35 | - |
0QZZ
6058
0FNZ
MYGN
5602
AZASF